Table II.

Clinicopathological parameters of patients with BC.

Clinicopathological parameters and characteristics	Patients, n (%)
Histological grade
II	121 (74.7)
III	41 (25.3)
Involved axillary lymph nodes
Negative	67 (41.4)
Positive	95 (58.6)
Pathological type
Invasive ductal carcinoma	157 (96.9)
Invasive lobular carcinoma	5 (3.1)
ER status
Negative	54 (33.3)
Positive	108 (66.7)
PR status
Negative	65 (40.1)
Positive	97 (59.9)
HER-2 status
Negative	117 (72.2)
Positive	45 (27.8)

BC, breast cancer; ER, estrogen receptor; PR, progesterone receptor.